Citation Impact
Citing Papers
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
Macrophages in immunoregulation and therapeutics
2023 Standout
Works of G. Chen being referenced
OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial
2018
OA01.08 A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRM+/T790M+ Advanced or Recurrent NSCLC Patients
2019